AVBP
ArriVent BioPharma, Inc.
28.50$
-5.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +40.1% | -15.2% | +28.3% | -7.8% | +0.4% | +204.0% | -54.8% | +16.0% | +0.0% | +16.9% | +12.6% | – | |
| – | +27.6% | +19.0% | +5.9% | +5.7% | -14.5% | +54.8% | +7.7% | +4.2% | +8.1% | +27.8% | +21.9% | – | |
| – | +38.3% | -10.6% | +24.3% | -5.7% | -2.2% | +181.7% | -49.6% | +14.0% | +1.3% | +18.8% | +14.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.